Clinical Trials | October 30, 2023
SN Bioscience announces Phase 1 study results of SN-38 nanoparticle anti-cancer drug
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
Diofan Ultra736 provides ultra-high water vapor barrier with excellent thermoformability, unlocking the potential to design thinner and more sustainable blister films
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
SÜDPACK customers also benefit when it comes to processing PharmaGuard
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
The two-part production system is proven to yield high-quality proteins from GS-CHO cell lines, a prevalent mammalian host cell for protein production
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
Subscribe To Our Newsletter & Stay Updated
